Search
Prenetics Global Ltd
PREAdd to Watchlist
22.930USD
+0.220+0.97%
Close 09-24 16:00（ET）
393.02MMarket Cap
LossP/E TTM
About Prenetics Global Ltd Company
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Prenetics Global Ltd Profile
Ticker SymbolPRE
Company namePrenetics Global Ltd
IPO dateJul 06, 2021
CEOKwok (Samantha)
Number of employees285
Security typeOrdinary Share
Fiscal year-endJul 06
AddressUnit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
City
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryHong Kong
Postal code- -
Phone85222109588
Websitehttps://ir.prenetics.com/
Ticker SymbolPRE
IPO dateJul 06, 2021
CEOKwok (Samantha)
Company Executives of Prenetics Global Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
167.42K
+17.16%
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
167.42K
+17.16%
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
167.42K
+17.16%
Mr. Hudson Leogrande
Mr. Hudson Leogrande
Independent Director
Independent Director
6.00K
+33.33%
Mr. Hudson Leogrande
Mr. Hudson Leogrande
Independent Director
Independent Director
6.00K
+33.33%
Mr. Hudson Leogrande
Mr. Hudson Leogrande
Independent Director
Independent Director
6.00K
+33.33%
Dr. Darshan Shah
Dr. Darshan Shah
Independent Director
Independent Director
4.51K
--
Dr. Darshan Shah
Dr. Darshan Shah
Independent Director
Independent Director
4.51K
--
Dr. Darshan Shah
Dr. Darshan Shah
Independent Director
Independent Director
4.51K
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
167.42K
+17.16%
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
167.42K
+17.16%
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
167.42K
+17.16%
Mr. Hudson Leogrande
Mr. Hudson Leogrande
Independent Director
Independent Director
6.00K
+33.33%
Mr. Hudson Leogrande
Mr. Hudson Leogrande
Independent Director
Independent Director
6.00K
+33.33%
Mr. Hudson Leogrande
Mr. Hudson Leogrande
Independent Director
Independent Director
6.00K
+33.33%
FAQs
Who are the top five shareholders of Prenetics Global Ltd?
The top five shareholders of Prenetics Global Ltd are: Mr. Sheng Wu (Danny) Yeung
How many institutions hold shares of Prenetics Global Ltd (PRE)?
As of 2026Q1, 46 institutions hold shares of Prenetics Global Ltd, with a combined market value of approximately 1.76M, accounting for 11.33% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -778478.00.